Made possible by the HIV Organ Policy Equity (HOPE) Act, Emory Transplant Center has performed its first HIV-positive kidney transplant from an HIV-positive deceased donor. Not only was this Emory’s first HIV to HIV...
Simone Whitehead was an active 30-year-old, running half marathons and chasing around her 2-year-old son. In April 2016, she began to feel ill, and she slowly started getting worse. Tests revealed that her liver...
Emory Transplant Center will soon begin enrolling patients into a new clinical trial that will test an FDA-approved drug in HIV positive patients receiving a kidney transplant. The research study will evaluate the safety...
The National Institutes of Minority Health and Health Disparities has awarded $2.6 million over five years to the Emory Transplant Center and six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition....
Emory is nationally renowned for using a multidisciplinary approach to treat cancer. But many may not know there is a multidisciplinary team right here at the Emory Transplant Center with the mission of improving...
A study of kidney transplant recipients has shown for the first time that the drug belatacept (Nulojix), which controls the immune system and prevents graft rejection, has a better record of patient and organ...
Because human airways are open to airborne fungal spores and pathogens, lung transplant patients are especially susceptible to infections, a major cause of post-transplant disease and even death. A reliable means of preventing fungal...
We all know good nutrition plays a critical role in overall health. But for transplant patients, good nutrition is especially important. Francoise Maillet, a clinical dietitian who works with the Emory Transplant Center, wrote...